Daclatasvir: potential role in hepatitis C
Choongho Lee College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea Abstract: Chronic hepatitis C virus (HCV) infection is responsible for the development of liver cirrhosis and hepatocellular carcinoma. It has been a tremendous burden on global health care systems. With...
Saved in:
Main Author: | Lee C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Daclatasvir: potential role in hepatitis C [Corrigendum]
by: Lee C
Published: (2014) -
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
by: Andrew Hill, et al.
Published: (2016) -
Efficacy and safety of daclatasvir-containing regimens in the treatment of chronic hepatitis C patients in Damietta
by: Alaa Eldeen M Hashim, et al.
Published: (2020) -
Frequency of Sustained Virologic Response in Hepatitis C Positive, Treatment Naïve Patients on Sofosbuvir and Daclatasvir
by: Islam Shah, et al.
Published: (2023) -
Retrospective study of hepatitis c virus relapse after treatment with sofosbuvir and daclatasvir with or without ribavirin
by: Mohamed DA Abd Alla, et al.
Published: (2018)